DE602004026879D1 - Orales abgabesystem mit einem biliquid foam - Google Patents

Orales abgabesystem mit einem biliquid foam

Info

Publication number
DE602004026879D1
DE602004026879D1 DE602004026879T DE602004026879T DE602004026879D1 DE 602004026879 D1 DE602004026879 D1 DE 602004026879D1 DE 602004026879 T DE602004026879 T DE 602004026879T DE 602004026879 T DE602004026879 T DE 602004026879T DE 602004026879 D1 DE602004026879 D1 DE 602004026879D1
Authority
DE
Germany
Prior art keywords
weight
biliquid foam
delivery system
oral delivery
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004026879T
Other languages
English (en)
Inventor
William Charman
Monica Dias
Michelle Georgiou
Philip Guffogg
Christopher Porter
Colin Pouton
Fraser Steele
Derek Wheeler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MC2 Therapeutics Ltd
Original Assignee
Drug Delivery Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Solutions Ltd filed Critical Drug Delivery Solutions Ltd
Publication of DE602004026879D1 publication Critical patent/DE602004026879D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DE602004026879T 2003-07-30 2004-07-30 Orales abgabesystem mit einem biliquid foam Active DE602004026879D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317869.6A GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system
PCT/GB2004/003329 WO2005011628A2 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam

Publications (1)

Publication Number Publication Date
DE602004026879D1 true DE602004026879D1 (de) 2010-06-10

Family

ID=27799499

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004026879T Active DE602004026879D1 (de) 2003-07-30 2004-07-30 Orales abgabesystem mit einem biliquid foam

Country Status (14)

Country Link
US (1) US20060228408A1 (de)
EP (1) EP1653923B1 (de)
JP (1) JP4953815B2 (de)
CN (2) CN101579311B (de)
AT (1) ATE465715T1 (de)
AU (1) AU2004261053B2 (de)
CA (1) CA2533833C (de)
DE (1) DE602004026879D1 (de)
DK (1) DK1653923T3 (de)
ES (1) ES2344898T3 (de)
GB (1) GB0317869D0 (de)
RU (1) RU2353350C2 (de)
WO (1) WO2005011628A2 (de)
ZA (1) ZA200600761B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404403D0 (en) 2004-02-27 2004-03-31 Disperse Ltd Dispersions
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
GB0712389D0 (en) * 2007-06-26 2007-08-01 Drug Delivery Solutions Ltd A Pharmaceutical composition
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
CN101780037B (zh) * 2010-02-03 2011-11-16 南昌大学 双嘧达莫自乳化给药系统及其制备方法
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
HUE045467T2 (hu) * 2011-03-14 2020-01-28 Drug Delivery Solutions Ltd Szemészeti készítmény
CA3023121A1 (en) * 2011-04-11 2012-10-18 Vitux Group As Oral pharmaceutical dispersion compositions
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
US4999198A (en) * 1989-03-23 1991-03-12 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Polyaphrons as a drug delivery system
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
ES2177936T3 (es) * 1996-03-08 2002-12-16 Disperse Ltd Dispersion estable consistente en una espuma biliquida basada en aceite y un gel acuoso.
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
ATE275378T1 (de) * 2000-02-22 2004-09-15 Color Access Inc Wässrige kosmetische gele
GB0214793D0 (en) * 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment

Also Published As

Publication number Publication date
JP2007500181A (ja) 2007-01-11
JP4953815B2 (ja) 2012-06-13
RU2353350C2 (ru) 2009-04-27
DK1653923T3 (da) 2010-08-09
WO2005011628A2 (en) 2005-02-10
CN101579311A (zh) 2009-11-18
EP1653923A2 (de) 2006-05-10
ATE465715T1 (de) 2010-05-15
CN101579311B (zh) 2013-11-27
WO2005011628A3 (en) 2005-05-06
RU2006106173A (ru) 2007-09-10
US20060228408A1 (en) 2006-10-12
GB0317869D0 (en) 2003-09-03
EP1653923B1 (de) 2010-04-28
CN1832727A (zh) 2006-09-13
CA2533833A1 (en) 2005-02-10
ZA200600761B (en) 2007-05-30
CA2533833C (en) 2013-05-28
AU2004261053B2 (en) 2011-08-25
AU2004261053A1 (en) 2005-02-10
ES2344898T3 (es) 2010-09-09

Similar Documents

Publication Publication Date Title
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
EP2402003A3 (de) Diclofenac-Formulierungen und Nutzungsverfahren
WO2005112633A3 (en) Compounds and compositions for delivering active agents
CY1111458T1 (el) Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
MY148773A (en) Galenic formulations of organic compounds
IT1318539B1 (it) Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
WO2008060934A8 (en) Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
AR108594A2 (es) Formulaciones farmacéuticas que conservan el sabor con características farmacéuticas mejoradas
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
MXPA05008909A (es) Formulacion intranasal de rotigotina.
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
NO20056241L (no) Nanopartikler av polyoksyetylenerte derivater
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
ATE465715T1 (de) Orales abgabesystem mit einem biliquid foam
WO2002015959A3 (en) Compounds and compositions for delivering active agents
WO2008056375A3 (en) Pharmaceutical formulations comprising valsartan
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
JP2007500181A5 (de)
WO2007065625A3 (en) Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations
EA200600953A1 (ru) Дозированные формы торсемида пролонгированного высвобождения

Legal Events

Date Code Title Description
8364 No opposition during term of opposition